TIGIT and cancer: Moreover, Zhang et al. demonstrated the significance of NK cells in cancer immunotherapy and noted that mAb targeting checkpoint molecule TIGIT, which is expressed by both T cells and NK cells, could improve the antitumor immunity of both T and NK cells.